Menopause and hormone therapy in the 21st century: why promote transdermal estradiol and progesterone?
- Resource Type
- Source
- Heart
Heart, 2020, 106 (16), pp.1278.1-1278. ⟨10.1136/heartjnl-2020-316907⟩
Heart, BMJ Publishing Group, 2020, 106 (16), pp.1278.1-1278. ⟨10.1136/heartjnl-2020-316907⟩ - Subject
medicine.medical_specialty Hormone Replacement Therapy medicine.medical_treatment Cardiovascular health 030204 cardiovascular system & hematology [SDV.MHEP.GEO]Life Sciences [q-bio]/Human health and pathology/Gynecology and obstetrics Coronary artery disease 03 medical and health sciences 0302 clinical medicine Internal medicine thromboembolic pulmonary vascular disease Epidemiology medicine Humans 030212 general & internal medicine Stroke Progesterone ComputingMilieux_MISCELLANEOUS Transdermal [SDV.MHEP.EM] Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism Estradiol business.industry Estrogens [SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism medicine.disease stroke 3. Good health Menopause [SDV.MHEP.GEO] Life Sciences [q-bio]/Human health and pathology/Gynecology and obstetrics Female epidemiology Hormone therapy Cardiology and Cardiovascular Medicine business coronary artery disease - Language
- English
- ISSN
- 1355-6037
1468-201X